This topic contains a solution. Click here to go to the answer

Author Question: In a graph of the results from multiple-baseline design using two participants, which feature ... (Read 129 times)

Davideckstein7

  • Hero Member
  • *****
  • Posts: 555
In a graph of the results from multiple-baseline design using two participants, which feature justifies a conclusion that the treatment causes changes in behavior?
 
  a. the size of the change in behavior each time the treatment is introduced
 b. the time delay between the introduction of the treatment and the first change in behavior for each participant
  c. the return to baseline behavior when the treatment is withdrawn for both participants
 d. demonstrating that the same change in behavior occurs when the treatment is introduced at different times for the participants

Question 2

In GLM equations, the letter z stands for the ____.
 
  a. outcome score
 b. error
 c. dummy variable
  d. predictor score



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ultraflyy23

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

d

Answer to Question 2

c




Davideckstein7

  • Member
  • Posts: 555
Reply 2 on: Jun 19, 2018
:D TYSM


dantucker

  • Member
  • Posts: 346
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Earwax has antimicrobial properties that reduce the viability of bacteria and fungus in the human ear.

Did you know?

As the western states of America were settled, pioneers often had to drink rancid water from ponds and other sources. This often resulted in chronic diarrhea, causing many cases of dehydration and death that could have been avoided if clean water had been available.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library